Cited by 3.1k
Harvard University
ORCID: 0000-0002-4493-4150Publishes on Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes, Renal Diseases and Glomerulopathies. 674 papers and 53.8k citations.
Add your photo, update your bio, and get notified when your ranking changes.
A murine monoclonal antibody (OC125) has been developed that reacts with each of six epithelial ovarian carcinoma cell lines and with cryopreserved tumor tissue from 12 of 20 ovarian cancer patients. By contrast, the antibody does not bind to a variety of nonmalignant tissues, including adult and fetal ovary. OC125 reacts with only 1 of 14 cell lines derived from nonovarian neoplasms and has failed to react with cryostat sections from 12 nonovarian carcinomas.